A new combination of drugs that may have the potential to treat a type of leukemia has been uncovered by a detailed molecular examination of leukemia cells by RIKEN researchers1.
Jun 28, 2021
0
11
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of ...
May 5, 2021
0
13
(Medical Xpress) -- There is no cure for multiple sclerosis, but several medications can help slow its devastating effects, and extend healthier years for the roughly 2.5 million people worldwide diagnosed with this chronic ...
Aug 9, 2012
0
0
A genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis has been approved for reimbursement by the Centers for Medicare ...
Feb 26, 2024
0
1
A professor at The University of New Mexico has developed a new, groundbreaking drug that that could revolutionize the diagnosis of infectious diseases.
Dec 2, 2016
0
2
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Dec 16, 2012
0
0
Results of a Phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy. The findings, reported by doctors at Wake Forest Baptist Medical Center, ...
Sep 8, 2014
0
0
A new chemotherapy drug being investigated for its potency against two types of cancer was found by scientists at Houston Methodist and seven other institutions to be effective in about one-third of the 58 patients who participated ...
May 23, 2014
0
0
St. Jude Children's Research Hospital scientists have evidence that an anti-malaria drug sensitizes a high-risk subtype of acute lymphoblastic leukemia (ALL) to treatment with a promising class of targeted drugs, raising ...
Dec 4, 2017
0
0
Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or ...
Jul 30, 2018
0
5
